Early trial tests novel Two-Drug attack on tough prostate cancer
NCT ID NCT07319871
Summary
This early-stage study is testing a new two-drug combination for men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. The main goals are to find a safe and tolerable dose of the drugs working together and to see how well the body handles them. The study will also look for early signs that the treatment might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Medical Center
RECRUITINGNew York, New York, 10032, United States
-
Florida Cancer Specialists
RECRUITINGSarasota, Florida, 34232, United States
-
Royal Marsden Hospital
RECRUITINGSutton, SM2 5PT, United Kingdom
Conditions
Explore the condition pages connected to this study.